Literature DB >> 3207563

Pharmacokinetics and haemodynamic effects of prolonged methohexitone infusion.

Y Le Normand1, C de Villepoix, M Pinaud, J M Bernard, J P Fraboul, A Athouel, M Ribeyrol, N Beneroso, C Larousse.   

Abstract

1. The use of continuous infusion anaesthesia has only been of interest since the development of short-acting, less cumulative and less toxic drugs. 2. This study aimed to compare pharmacokinetics and haemodynamic effects during and after long time methohexitone constant rate infusion. Sixteen patients were given either 60 or 90 micrograms kg-1 min-1 methohexitone during 14 h. Blood samples were taken hourly during this time and 12 h following the end of infusion. 3. Infusion period was analysed by a single exponential model; post-infusion time showed a three compartment model, the intermediate phase parameters corresponding to those of the infusion period. 4. Methohexitone was haemodynamically well tolerated; prolonged infusion decreases oxygen consumption, mainly by a decrease in oxygen demand. 5. Many patients remained unconscious for unacceptably long periods of time after post-operative sedation by methohexitone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207563      PMCID: PMC1386636          DOI: 10.1111/j.1365-2125.1988.tb05299.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Physiologic disposition of methohexital in man.

Authors:  L BRAND; L C MARK; M M SNELL; P G VRINDTEN P DAYTON
Journal:  Anesthesiology       Date:  1963 May-Jun       Impact factor: 7.892

2.  Methohexitone and the E.E.G.

Authors:  J Gumpert; P Hansotia; R Paul; A Upton
Journal:  Lancet       Date:  1969-07-12       Impact factor: 79.321

Review 3.  General kinetic and dynamic principles and their application to continuous infusion anaesthesia.

Authors:  J W Sear
Journal:  Anaesthesia       Date:  1983-07       Impact factor: 6.955

4.  Pharmacokinetics of methohexital and thiopental in surgical patients.

Authors:  R J Hudson; D R Stanski; P G Burch
Journal:  Anesthesiology       Date:  1983-09       Impact factor: 7.892

5.  Seizures induced by methohexital.

Authors:  K Metriyakool
Journal:  Anesthesiology       Date:  1981-12       Impact factor: 7.892

6.  Seizures induced by methohexital.

Authors:  M A Rockoff; N G Goudsouzian
Journal:  Anesthesiology       Date:  1981-04       Impact factor: 7.892

7.  Controlled sedation with alphaxalone-alphadolone.

Authors:  M A Ramsay; T M Savege; B R Simpson; R Goodwin
Journal:  Br Med J       Date:  1974-06-22

8.  Pharmacokinetics of methohexitone following intravenous infusion in humans.

Authors:  D D Breimer
Journal:  Br J Anaesth       Date:  1976-07       Impact factor: 9.166

9.  Hemodynamic and hepatic effects of methohexital infusion during nitrous oxide anesthesia in humans.

Authors:  C Prys-Roberts; J W Sear; J M Low; K C Phillips; J Dagnino
Journal:  Anesth Analg       Date:  1983-03       Impact factor: 5.108

10.  The hemodynamic consequences of high-dose methohexital anesthesia in humans.

Authors:  M M Todd; J C Drummond; H S U
Journal:  Anesthesiology       Date:  1984-11       Impact factor: 7.892

  10 in total
  2 in total

1.  Non linear disposition of thiopentone following long-term infusion.

Authors:  P Le Corre; Y Malledant; M Tanguy; R Le Verge
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jul-Sep       Impact factor: 2.441

2.  Mechanistic approaches to volume of distribution predictions: understanding the processes.

Authors:  Trudy Rodgers; Malcolm Rowland
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.